Ekram Hanna, MD
Internal Medicine · Bridgeton, NJNPI 1730273772
Payments from drug & device makers
Across 376 payments — averaging $989.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi US Services Inc.$124K
- Pfizer$99K
- Eli Lilly$76K
- AbbVie$46K
- Merck$24K
- Bayer$1K
- plus $2K from 19 others
Across 19 payments — averaging $1794.05 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$31K
- Sanofi US Services Inc.$2K
- AbbVie$1K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi US Services Inc. | 142 | $124,270 |
| Pfizer | 33 | $99,050 |
| Eli Lilly | 5 | $75,574 |
| AbbVie(2 entities) | 35 | $46,446 |
| Merck | 22 | $23,827 |
| Bayer | 1 | $1,159 |
| Novo Nordisk | 24 | $325 |
| GSK | 24 | $290 |
| Amgen | 19 | $256 |
| Johnson & Johnson | 12 | $163 |
| Amarin Pharma, Inc. | 12 | $153 |
| AstraZeneca | 8 | $104 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $73 |
| Sunovion Pharmaceuticals Inc. | 6 | $71 |
| Akcea Therapeutics, Inc. | 1 | $71 |
| Philips North America LLC | 4 | $63 |
| Astellas Pharma US Inc | 5 | $58 |
| Novartis | 4 | $57 |
| Kowa Pharmaceuticals America, Inc. | 4 | $51 |
| Lilly USA, LLC | 4 | $51 |
| Sanofi-aventis U.S. LLC | 2 | $30 |
| Abbott | 1 | $21 |
| Circassia Inc. | 1 | $13 |
| Seqirus USA Inc | 1 | $13 |
| E.r. Squibb & Sons, L.L.C. | 1 | $13 |
How this compares
$372,199 in reported general payments places this provider in the 95th percentile of 4,032 internal medicine providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other internal medicine in Bridgeton
- Sanjiv SharmaToms River$33.9M
- Jeffrey CarsonNew Brunswick$13.8M
- Samer HaddadHamilton$6.8M
- Magdy ShenoudaWall$3.7M
- Samar HameedLivingston$3.6M
- Jane RohlfTrenton$2.7M
- Mohammed NisarEdison$2.6M
- Michael CasserNew Milford$2.2M
- Sumitha ReddyHamilton$2M
- Helio PedroNewark$1.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.